seffalair spiromax
teva b.v. - fluticasone propionate, salmeterol xinafoate - asma - medicamentos para la enfermedad obstructiva de las vías respiratorias enfermedades, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.
anapen 0,50 mg/0,3 ml solucion inyectable en jeringa precargada
bioprojet pharma - epinefrina - soluciÓn inyectable en jeringa precargada - 500 microgramos inyectable 0,3 ml - epinefrina 1700 microgramos - epinefrina